Skip to main content
Clinical Trials/NCT04082663
NCT04082663CompletedNot Applicable

Evaluating the Effects of a Removable Dental Mouthpiece on Symptoms Associated With Parkinson's

Washington University School of Medicine1 site in 1 country20 target enrollmentStarted: September 19, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Changes in Mini-Balance Evaluation Systems Test (Mini-BESTest)

Study Overview

Brief Summary

The investigators are evaluating the immediate effect of a dental mouthpiece on gait and balance among people with Parkinson disease as well as longer-term feasibility use and the effect of the mouthpiece on sleep and quality of life.

Detailed Description

The investigators are conducting a pilot study with participants who have been diagnosed with Parkinson disease recruited from the community. Participants will attend one in-person visit and be custom fitted with a dental mouthpiece. Participants will be asked to wear the mouthpiece as much as possible for one month including while sleeping and during the day, except while eating.

Participants will be asked to return for a second in-person visit to repeat gait and balance (motor) measures.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
30 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •have a diagnosis of idiopathic, typical Parkinson Disease according to the United Kingdom Brain Bank Criteria, Hoehn & Yahr stages 1-3;
  • •stable Parkinson disease medications for the two weeks prior to baseline visit;
  • •be able to walk at least 10 meters at baseline with or without an assistive device;
  • •have their own teeth and/or dentures;
  • •be willing to try to wear a mouthpiece for one month;
  • •are over the age of 30; and
  • •provide written or verbal informed consent.

Exclusion Criteria

  • •pre-existing medical conditions that would inhibit full participation in the study's tasks;
  • •absence of any dentition;
  • •cognitive impairments indicated by Mini Mental Status Exam (MMSE) score of <24;
  • •freezing of gait which moderately or severely impacts walking; or
  • •current use of an oral appliance (e.g., a dental mouthpiece, retainer, or braces).

Arms & Interventions

Dental Mouthpiece

Experimental

Each participant will be fitted with a maxillary orthotic (mouthpiece). The mouthpiece is fabricated with polyvinyl ethylene acetate which is non-toxic to humans.

Intervention: Dental Mouthpiece (Device)

Outcomes

Primary Outcomes

Changes in Mini-Balance Evaluation Systems Test (Mini-BESTest)

Time Frame: Baseline in-person visit

Balance will be measured with the Mini-Balance Evaluation Systems Test (Mini-BESTest) with and without the mouthpiece. The assessment includes 14 items each of which is rated on a three-point scale (2: Normal, 1: Moderate, 0: Severe). The 14 item scores are summed for a total score. The range of scores is 0 to 28, and higher scores indicate better balance function.

Changes in Gait Velocity

Time Frame: Baseline in-person visit

Gait velocity will be measured while walking forwards with and without the mouthpiece

Secondary Outcomes

  • Changes in Parkinson Disease Questionnaire-39(Baseline and One month)
  • Changes in Parkinson Disease Sleep Scale(Baseline and One month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gammon M Earhart

Director, Program in Physical Therapy

Washington University School of Medicine

Study Sites (1)

Loading locations...

Similar Trials